Musculoskeletal
Lumbar Spinal Stenosis
5
Pipeline Programs↗
3
Active Trials↗
2
Companies Involved↗
Lumbar Spinal Stenosis is an early-stage landscape with 5 programs across 2 companies. The most active players are Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Stryker Instruments. 2 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical3
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Analysis
Trial Status
9
clinical trials
Completed4 · 44%
Withdrawn1 · 11%
Terminated1 · 11%
Active, not recruiting1 · 11%
Recruiting1 · 11%
Not yet recruiting1 · 11%
Clinical Trials
Trial Activity
9 trials
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Recruiting·—·N/A·NCT03072927·8,000 enrolled
Effect of Obesity Phenotype on Intraabdominal Pressure, Intraoperative Bleeding, and Perioperative Complications in Patients Undergoing Major Lumbar Spinal Surgery: A Prospective Observational Study
Not yet recruiting·Marmara University Pendik Training and Research Hospital·N/A·NCT07688265·90 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)